Lilly World's Best-Selling Drug: Is the Stock a Buy Now?
Eli Lilly's ascent to the top of the drug charts centers on a single family of medicines. This article breaks down wh...
Creating a financial plan? Learn what to include to ensure your success and financial stability for the future.
23,717 articlesEli Lilly's ascent to the top of the drug charts centers on a single family of medicines. This article breaks down wh...
A Senate Banking Committee vote signaling bipartisan support for the CLARITY Act could unlock a clearer path for Bitc...
The Cleveland Fed reports the five-year inflation outlook hasn’t been this high in 19 years, adding a new twist for i...
Drew Barrymore’s 280-year-old Westchester weekend retreat has secured a buyer, after listing for $4.99 million. The d...
The CLARITY Act aims to separate crypto oversight between the SEC and CFTC while probing foreign adversary risks. Cri...
A Friday announce could insert Marvell into the S&P 500 after a dramatic stock surge. The company's market cap dwarfs...
A new AI-driven outlook on XRP is stirring market chatter as XRP hovers around $1.14. Analysts weigh whether the pred...
May wholesale prices rose again for the second straight month, marking the largest back-to-back gain since 2022 and s...
When SpaceX surged, several smaller space stocks fell hard. Was it just rotation, or a signal to rethink the sector? ...
The Pentagon reports a dramatic rise in AI usage, but fewer than half of employees are actively using tools. Experts ...
A $1 million horror film defies expectations while a 30-year-old franchise returns with a bold new installment, deliv...
Glenn Kelman has joined Greylock Partners as an executive in residence, months after stepping down from Redfin and fo...